BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28109906)

  • 1. Succinate in the cancer-immune cycle.
    Jiang S; Yan W
    Cancer Lett; 2017 Apr; 390():45-47. PubMed ID: 28109906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate: a metabolic signal in inflammation.
    Mills E; O'Neill LA
    Trends Cell Biol; 2014 May; 24(5):313-20. PubMed ID: 24361092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of succinate dehydrogenase and role of succinate in cancer.
    Dalla Pozza E; Dando I; Pacchiana R; Liboi E; Scupoli MT; Donadelli M; Palmieri M
    Semin Cell Dev Biol; 2020 Feb; 98():4-14. PubMed ID: 31039394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succinate as a signaling molecule in the mediation of liver diseases.
    Chen H; Jin C; Xie L; Wu J
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166935. PubMed ID: 37976628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers.
    Murphy MP; O'Neill LAJ
    Cell; 2018 Aug; 174(4):780-784. PubMed ID: 30096309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Engineering of TCA Cycle for Production of Chemicals.
    Vuoristo KS; Mars AE; Sanders JPM; Eggink G; Weusthuis RA
    Trends Biotechnol; 2016 Mar; 34(3):191-197. PubMed ID: 26702790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate is an inflammatory signal that induces IL-1β through HIF-1α.
    Tannahill GM; Curtis AM; Adamik J; Palsson-McDermott EM; McGettrick AF; Goel G; Frezza C; Bernard NJ; Kelly B; Foley NH; Zheng L; Gardet A; Tong Z; Jany SS; Corr SC; Haneklaus M; Caffrey BE; Pierce K; Walmsley S; Beasley FC; Cummins E; Nizet V; Whyte M; Taylor CT; Lin H; Masters SL; Gottlieb E; Kelly VP; Clish C; Auron PE; Xavier RJ; O'Neill LA
    Nature; 2013 Apr; 496(7444):238-42. PubMed ID: 23535595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
    Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
    Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The γ-aminobutyric acid shunt contributes to closing the tricarboxylic acid cycle in Synechocystis sp. PCC 6803.
    Xiong W; Brune D; Vermaas WF
    Mol Microbiol; 2014 Aug; 93(4):786-96. PubMed ID: 24989231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple faces of succinate beyond metabolism in blood.
    Grimolizzi F; Arranz L
    Haematologica; 2018 Oct; 103(10):1586-1592. PubMed ID: 29954939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Warburg effect then and now: from cancer to inflammatory diseases.
    Palsson-McDermott EM; O'Neill LA
    Bioessays; 2013 Nov; 35(11):965-73. PubMed ID: 24115022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediates of Metabolism: From Bystanders to Signalling Molecules.
    Haas R; Cucchi D; Smith J; Pucino V; Macdougall CE; Mauro C
    Trends Biochem Sci; 2016 May; 41(5):460-471. PubMed ID: 26935843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestine is a major contributor to circulating succinate in mice.
    Tong W; Hannou SA; Wang Y; Astapova I; Sargsyan A; Monn R; Thiriveedi V; Li D; McCann JR; Rawls JF; Roper J; Zhang GF; Herman MA
    FASEB J; 2022 Oct; 36(10):e22546. PubMed ID: 36106538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling.
    Bénit P; Letouzé E; Rak M; Aubry L; Burnichon N; Favier J; Gimenez-Roqueplo AP; Rustin P
    Biochim Biophys Acta; 2014 Aug; 1837(8):1330-7. PubMed ID: 24699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
    Smith EH; Janknecht R; Maher LJ
    Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer.
    Zhang W; Lang R
    Front Cell Dev Biol; 2023; 11():1266973. PubMed ID: 37808079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels.
    Cordes T; Wallace M; Michelucci A; Divakaruni AS; Sapcariu SC; Sousa C; Koseki H; Cabrales P; Murphy AN; Hiller K; Metallo CM
    J Biol Chem; 2016 Jul; 291(27):14274-14284. PubMed ID: 27189937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional roles of TCA cycle metabolites in cancer.
    Eniafe J; Jiang S
    Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonezymatic formation of succinate in mitochondria under oxidative stress.
    Fedotcheva NI; Sokolov AP; Kondrashova MN
    Free Radic Biol Med; 2006 Jul; 41(1):56-64. PubMed ID: 16781453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
    Tretter L; Patocs A; Chinopoulos C
    Biochim Biophys Acta; 2016 Aug; 1857(8):1086-1101. PubMed ID: 26971832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.